Answers are grounded in this paper and cite their sources.
Individuals with type 2 diabetes (T2D) and chronic kidney disease (CKD) face high risks of depression and mortality. This study evaluated the prevalence and predictors of depression, and its relationship with all-cause mortality, in American adults with T2D stratified by CKD status. Data from the National Health and Nutrition Examination Survey, linked to National Death Index mortality data, were analyzed. Logistic regression evaluated predictors of depression. Survey-weighted multivariable Cox proportional hazards models—evaluating the T2D cohort with an interaction term (Depression × CKD) and adjusted for eGFR categories—assessed all-cause mortality. The study included 19,032 participants: healthy (n = 13,086), T2D (n = 3394), diabetic CKD (n = 1055), and non-T2D CKD (n = 1326). Depression was prevalent in 13.68% of individuals with CKD and was associated with female sex, smoking, obesity, and lower income. Furthermore, multivariable analyses demonstrated no independent association between glycemic control tiers and depression status. In the fully adjusted T2D survival model, CKD status (aHR = 2.44, p < 0.001) and severe eGFR reductions (<30 mL/min/1.73 m2, aHR = 3.93, p < 0.001) were robust, independent predictors of mortality. Comorbid depression showed a non-significant main effect (aHR = 0.61, p = 0.101), and the Depression × CKD interaction was non-significant (aHR = 1.64, p = 0.157), indicating no unique synergistic mortality multiplier tied to renal status. Because depression and declining renal function independently compound health risks, early identification and integrated mental health support remain critical priorities in cardiorenal care.
No takes yet. Share an insight, caveat, or question.
Purohit et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: